Thaindian News

April 15, 2010 (Pen Men at Work): Investigators have identified a gene variant that almost doubles the danger of building late-onset Alzheimer’s disease. This data is in line with a new study.

An American investigative team has analyzed the gene differences across the human genome or full DNA sequence, of 2,269 individuals with late-onset Alzheimer’s and 3,107 people without the disease.

This research has been titled as a genome-wide association study. It observes throughout the complete genome for tiny disparities, or variants, in extensive stretches of DNA that are more common in those with a particular illness or condition.

About 9 percent of those with late-onset Alzheimer’s had a particular variation in the gene MTHFD1L on chromosome 6, in keeping with the study. Approximately 5 percent of those, who did not possess Alzheimer’s, had the variant.

Late-onset Alzheimer’s, which plagues the people mostly above the age of 60 years, is the most widespread type of the brain disorder.

The World Health Organization (WHO) has stated that the number of individuals with Alzheimer’s is likely to double from 18 million universally to 34 million by 2025. The examiners have been looking for genes that enact a role in Alzheimer’s disease. The desire is that comprehending the jobs of the genes could facilitate in creating superior treatments, which are greatly lacking at present.

So far, the principal known genetic supplier to late-onset Alzheimer’s is a variant of the gene APOE on chromosome 19. The Alzheimer’s-linked APOE variant takes place in about 40 percent of the people who experience late-onset Alzheimer’s.